| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $93.5M | — | +16.9% |
| Cost of Revenue | $25.2M | — | +24.8% |
| Gross Profit | $68.3M | — | +14.3% |
| R&D Expense | $25.3M | — | +7.6% |
| SG&A Expense | $16.3M | — | +0.2% |
| Pre-tax Income | -$22.2M | — | -3.4% |
| Income Tax | $1.1M | — | +40.1% |
| Net Income | -$23.3M | — | -4.7% |
| EPS (Basic) | -$0.17 | — | +0.0% |
| EPS (Diluted) | -$0.17 | — | +0.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $86.6M | +6.7% | -34.0% |
| Short-term Investments | $95.3M | -14.0% | +22.4% |
| Accounts Receivable | $40.9M | +74.6% | -2.0% |
| Current Assets | $263.2M | +2.5% | -8.0% |
| Total Assets | $401.7M | -4.5% | -9.9% |
| Current Liabilities | $173.7M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$11.6M | — | -44.7% |
| Capital Expenditures | $435K | — | -0.9% |
| Investing Cash Flow | $42.1M | — | +259.7% |
| Financing Cash Flow | -$25.0M | — | -310.6% |
| Free Cash Flow | -$12.0M | — | -42.3% |
| +14.9% |
| Total Liabilities | $184.4M | +5.2% | +18.0% |
| Stockholders' Equity | $217.3M | -11.4% | -24.9% |